Shares of Allergan rose 0.8 percent to $237.85 in mid-morning trading. Icahn, who did not disclose details of the stake, said in a statement on his website that he was confide ..
Celator Pharmaceuticals ranked No. 1 on Goldman Sachs' lists of stocks with 'the largest increase in hedge fund concentration' during the first quarter. ..
Starbucks founder, chairman and CEO Howard Schultz is considered one of the best business leaders of our generation. But he has also been outspoken on a range of political and ..
In American Wal-Marts, customers don't get to fondle their fish. But America is not China, as the world's biggest retailer has learned. ..
The trial of Lionel Messi on charges of tax evasion opened in Barcelona on Tuesday, but injury prevented soccer's five-times World Player of the Year from attending. The ..
The activist investor also gives a pat on the back for Allergan's CEO. ..
Michael Pearson, the former chief executive officer of Valeant Pharmaceuticals International (VRX.TO), will receive a $9 million severance payment and agreed to a consulting a ..
Saudi Arabia is considering the sale of as much as $15 billion of bonds this year, encouraged by investor demand for Qatar’s recent issue, people with knowledge of the matter ..
The U.S. Supreme Court on Tuesday declined to hear Sprint Corp's bid to avoid a lawsuit filed by New York state that seeks $300 million and claims the company deliberately did ..
WASHINGTON (AP) — U.S. home prices kept climbing in March as the spring home buying season began, but so far the higher costs haven't thwarted sales. ..
Risk Disclosure: fxBrokerSearch.com will not be held liable for any financial loss or damage caused by users acting upon any information contained within this website, not limited to and including: all numerical data, quotes, charts and buy/sell signals. Moreover, please be advised that Forex trading is one of the most volatile investment forms in the world and all trades should be placed with full consideration of the risks and costs.
fxBrokerSearch.com does not support nor encourage the execution of any investments. Trading with a margin is high risk endeavour and not suitable for everyone, therefore, each investor should carefully consider all relevant trading conditions, such as experience, risk and cost, before taking part in any type of trading, including Forex.
While every effort has been made to ensure all our data is as accurate as possible, fxBrokerSearch.com cannot be held responsible for any prices that are not in line with real-time data. Indeed, the currency exchange market is constantly changing and all CFDs (stocks, indexes, futures) and Forex prices are set by market makers.
This means advertised prices may not be accurate and could differ from the actual market conditions. For this reason it is not appropriate to rely on any data presented by fxBrokerSearch.com for the purposes of trading.
Based on these conditions, fxBrokerSearch.com will not be held responsible for any losses incurred through trades conducted in light of data presented on this site.